Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic B Rowe

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Environmental Research and Public Health|December 26, 2015
A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in AustraliaMark A S Laidlaw, Dominic B Rowe, Andrew S Ball, et al.
The Lancet. Neurology|March 22, 2005
Assessment of disease progression in motor neuron diseaseJennica M C Winhammar, Dominic B Rowe, Robert D Henderson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2019
CMS-01 Genetic testing for familial amyotrophic lateral sclerosis (ALS): insights and challengesAshley Crook, Anne Hogden, Virginia Mumford, et al.
Environmental Research|December 20, 2016
Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in AustraliaSammy Zahran, Mark A S Laidlaw, Dominic B Rowe, et al.
Neuroimage. Clinical|July 30, 2019
Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosisThomas Welton, Jerome J Maller, R Marc Lebel, et al.
Neuropharmacology|June 7, 2016
Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosisJong-Min Lee, Vanessa Tan, David Lovejoy, et al.
Frontiers in Surgery|April 27, 2019
Limitations of Electromyography in the Assessment of Abdominal Wall Muscle Contractility Following Botulinum Toxin A InjectionRodrigo Tomazini Martins, Kristen E Elstner, Christian Skulina, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 26, 2019
The <i>C9orf72</i> hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counselingAshley Crook, Alison McEwen, Jennifer A Fifita, et al.
Journal of Proteome Research|May 19, 2020
Metabolite Profiling Reveals Predictive Biomarkers and the Absence of β-Methyl Amino-l-alanine in Plasma from Individuals Diagnosed with Amyotrophic Lateral SclerosisMichael S Bereman, Kaylie I Kirkwood, Tharani Sabaretnam, et al.
Neuropathology and Applied Neurobiology|October 11, 2023
RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discoveryNatalie Grima, Sidong Liu, Dean Southwood, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Environmental Research and Public Health|December 26, 2015
A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in AustraliaMark A S Laidlaw, Dominic B Rowe, Andrew S Ball, et al.
The Lancet. Neurology|March 22, 2005
Assessment of disease progression in motor neuron diseaseJennica M C Winhammar, Dominic B Rowe, Robert D Henderson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2019
CMS-01 Genetic testing for familial amyotrophic lateral sclerosis (ALS): insights and challengesAshley Crook, Anne Hogden, Virginia Mumford, et al.
Environmental Research|December 20, 2016
Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in AustraliaSammy Zahran, Mark A S Laidlaw, Dominic B Rowe, et al.
Neuroimage. Clinical|July 30, 2019
Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosisThomas Welton, Jerome J Maller, R Marc Lebel, et al.
Neuropharmacology|June 7, 2016
Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosisJong-Min Lee, Vanessa Tan, David Lovejoy, et al.
Frontiers in Surgery|April 27, 2019
Limitations of Electromyography in the Assessment of Abdominal Wall Muscle Contractility Following Botulinum Toxin A InjectionRodrigo Tomazini Martins, Kristen E Elstner, Christian Skulina, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 26, 2019
The <i>C9orf72</i> hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counselingAshley Crook, Alison McEwen, Jennifer A Fifita, et al.
Journal of Proteome Research|May 19, 2020
Metabolite Profiling Reveals Predictive Biomarkers and the Absence of β-Methyl Amino-l-alanine in Plasma from Individuals Diagnosed with Amyotrophic Lateral SclerosisMichael S Bereman, Kaylie I Kirkwood, Tharani Sabaretnam, et al.
Neuropathology and Applied Neurobiology|October 11, 2023
RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discoveryNatalie Grima, Sidong Liu, Dean Southwood, et al.
Pageof 6